Demonstrates improved fouling release and antimicrobial activity in ultrafiltration membranes, suggesting a novel solution for biofouling issues.
We report the development of a membrane surface featuring both fouling release and antimicrobial properties, incorporating biocidal and fouling release structural motifs. The ultrafiltration membrane surface is modified by the PEGylated cross-linked micelles of partially alkylated poly(vinyl imidazole) followed by brief solvent evaporation to obtain an interconnected micelles network via intra- and intermicellar cross-linking and alkyl chain entanglement. The resulting PEGylated micellar coating endows the membrane surface with strong antimicrobial and biofilm inhibition activity. The modified membrane (MUF-PEG2k) displays good antifouling/antibiofouling performance during the separation of emulsified oil, protein, and bacteria with flux recovery ratios of 86.6%, 86%, and 93%, respectively, after total 40 h of test. The combined effects of low-surface-energy alkyl and polar hydrophilic PEG chains promote fouling release activity, while quaternized amine groups and lipophilic alkyl segments provide antimicrobial and biofilm inhibition properties. Glass and 96-cell well surfaces are also modified by this process. This strategy offers a platform for engineering robust, multifunctional membrane surfaces toward sustainable separation and biofouling mitigation.
No takes yet. Share an insight, caveat, or question.
Biswas et al. (2026) studied this question.
Synapse has enriched 5 closely related papers on similar clinical questions. Consider them for comparative context: